[
  {
    "ts": "2025-08-10T14:38:00+00:00",
    "headline": "2 Stocks to Buy With $5,000 and Hold for a Decade",
    "summary": "These two stocks come from completely different industries, but each could boost a long-term investor's returns.",
    "url": "https://www.fool.com/investing/2025/08/10/2-stocks-to-buy-with-5000-and-hold-for-a-decade/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "1b6a1e11-5adf-38d1-8dbb-797e6e685187",
      "content": {
        "id": "1b6a1e11-5adf-38d1-8dbb-797e6e685187",
        "contentType": "STORY",
        "title": "2 Stocks to Buy With $5,000 and Hold for a Decade",
        "description": "",
        "summary": "These two stocks come from completely different industries, but each could boost a long-term investor's returns.",
        "pubDate": "2025-08-10T14:38:00Z",
        "displayTime": "2025-08-10T14:38:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/c57ba8df45159a039382165a3ad31175",
          "originalWidth": 1400,
          "originalHeight": 952,
          "caption": "A person holding a fan of $100 bills.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fX8uJmoQ3ETrDKw3AJ_3LQ--~B/aD05NTI7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/c57ba8df45159a039382165a3ad31175.cf.webp",
              "width": 1400,
              "height": 952,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gP5eRgZaR6WdAKbMeyS1lQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/c57ba8df45159a039382165a3ad31175.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/08/10/2-stocks-to-buy-with-5000-and-hold-for-a-decade/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-stocks-buy-5-000-143800052.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RDDT"
            },
            {
              "symbol": "ZTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-10T03:59:52+00:00",
    "headline": "BofA Kept $200 Target on Zoetis (ZTS) as Competitive Threat Seen Modest",
    "summary": "Zoetis Inc. (NYSE:ZTS) is one of the best defensive stocks to invest in according to analysts. On July 10, Bank of America analyst Michael Ryskin reaffirmed a Buy rating on Zoetis with an unchanged price target of $200. His view remains constructive despite the recent FDA approval of Merck’s Bravecto Quantum, a new product that some […]",
    "url": "https://finance.yahoo.com/news/bofa-kept-200-target-zoetis-035952812.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "73ff1f9d-097b-3e59-971f-9460afda4814",
      "content": {
        "id": "73ff1f9d-097b-3e59-971f-9460afda4814",
        "contentType": "STORY",
        "title": "BofA Kept $200 Target on Zoetis (ZTS) as Competitive Threat Seen Modest",
        "description": "",
        "summary": "Zoetis Inc. (NYSE:ZTS) is one of the best defensive stocks to invest in according to analysts. On July 10, Bank of America analyst Michael Ryskin reaffirmed a Buy rating on Zoetis with an unchanged price target of $200. His view remains constructive despite the recent FDA approval of Merck’s Bravecto Quantum, a new product that some […]",
        "pubDate": "2025-08-10T03:59:52Z",
        "displayTime": "2025-08-10T03:59:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/402650839f690a34a37218bc19fa78f9",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "BofA Keeps $200 Target on Zoetis (ZTS) as Competitive Threat Seen Modest",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AF7NKfzOVsIboEy3qTUboA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/402650839f690a34a37218bc19fa78f9.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/K306pQr_h_rx63Bj.ngX2Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/402650839f690a34a37218bc19fa78f9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bofa-kept-200-target-zoetis-035952812.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bofa-kept-200-target-zoetis-035952812.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZTS"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]